Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Preventing diabetes means preventing cancer

No. 69 | 11/11/2020 | by Koh

On the occasion of World Diabetes Day on November 14, the German Cancer Research Center (DKFZ) is providing information about the links between cancer and diabetes – and why a healthy lifestyle can reduce the risk for both of these serious diseases at the same time.

A healthy lifestyle reduces the risk of diabetes and cancer
© Adobe Stock

Type 2 diabetes is increasing across the globe: according to the World Health Organization (WHO), 108 million people were affected by this serious metabolic disorder in 1980, but the figure had already risen to 422 million by 2014. There is a particularly strong increase in the number of people with diabetes in emerging economies. In Germany, around 500,000 people are diagnosed with diabetes for the first time every year.

During recent years, a large number of epidemiological studies have confirmed that people with diabetes have a considerably greater risk of developing cancer. In 2018, a meta-analysis by Australian researchers* showed that the cancer risk for men with diabetes is 19% higher than in the general population, and 27% higher for women with diabetes. A current publication** by scientists from the DKFZ and the National Center for Tumor Diseases (NCT) Heidelberg confirms this link for colorectal cancer, particularly for disease at a younger age.

Yet how can type 2 diabetes affect the development of cancer? Experts now assume that the risk of cancer is already higher even before type 2 diabetes is diagnosed: in many cases, diabetes itself is often preceded by a derailed metabolism known as metabolic syndrome. The syndrome is characterized by four main features: obesity, particularly around the waist; dysregulation of blood lipids; high blood pressure; and high blood sugar, often already associated with insulin resistance.

"Metabolic syndrome is thus also referred to as the deadly quartet," remarked Mathias Heikenwälder, metabolism expert at the DKFZ. "Excess fat around the waist is particularly dangerous in terms of developing cancer," he added, "because this fatty tissue releases messenger substances – adiponectins and cytokines – into the surrounding cells that trigger inflammatory reactions and reduce the effect of insulin. Some of these messenger substances also act as growth factors. They promote cell division in other cells and are thus conducive to tumor growth too." Moreover, the fat cells produce estrogens, which can stimulate cell growth in hormone-sensitive breast and uterine tissue.

If the metabolic syndrome exists over a period of many years, this may lead to type 2 diabetes; other common secondary diseases include arteriosclerosis, heart attack, stroke – and cancer.

However, the serious health problems caused by the metabolic syndrome can be averted; the development of disease can be halted by lifestyle changes. "Diet and exercise are the areas that those affected need to address," explained medical professional Susanne Weg-Remers, head of the Cancer Information Service at the DKFZ. That primarily means taking care to eat a balanced diet and maintain an energy balance. Regular exercise, if possible for 30 minutes a day, is equally important. Exercise increases energy expenditure and thus helps to reduce excess weight. However, Weg-Remers also knows how difficult most people find it to change long-standing unhealthy habits. "But it is worth it: If you take consistent action in time, you can considerably reduce your individual risk of developing cancer and other serious secondary diseases of the metabolic syndrome."

World Diabetes Day was launched by the International Diabetes Federation and WHO. It was first celebrated on November 14, 1991 and became an official United Nations Day in 2007. The date chosen for the day, November 14, was the birthday of Sir Frederick Banting, who discovered insulin with his colleague Charles Best in 1922.

* Toshiaki Ohkuma, Diabetology 2018, DOI:

** Uzair Ali Khan, Mahdi Fallah, Yu Tian, Kristina Sundquist, Jan Sundquist, Hermann Brenner, and Elham Kharazmi: Personal History of Diabetes as Important as Family History of Colorectal Cancer for Risk of Colorectal Cancer: A Nationwide Cohort Study
Am J Gastroenterol 2020, DOI:


With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS